Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia
Clinical trial NCT04001010 · SUSPENDED
Trial details
- NCT number
- NCT04001010
- Sponsor
- Tetra Bio-Pharma
- Status
- SUSPENDED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-07-01
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.